This HTML5 document contains 171 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q45297326
rdf:type
wikibase:Item
schema:description
naučni članak επιστημονικό άρθρο scientific article published on 2 September 2016 мақолаи илмӣ articol științific artikulong pang-agham videnskabelig artikel 2016年學術文章 научна статия 2016年の論文 scienca artikolo wissenschaftlicher Artikel artikel ilmiah artigo científico artykuł naukowy ২ সেপ্টেম্বর ২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artículo científico publicado en 2016 bài báo khoa học 2016年学术文章 2016年學術文章 наукова стаття, опублікована у вересні 2016 tieteellinen artikkeli bilimsel makale vedecký článok ശാസ്ത്രപ്രബന്ധം​ vitskapeleg artikkel 2016年学术文章 artigo científico 2016年学术文章 научни чланак مقالة علمية نشرت في 2 سبتمبر 2016 article científic scientific article published on 2 September 2016 2016年學術文章 tudományos cikk 2016 nî lūn-bûn vitenskapelig artikkel 2016년 논문 vetenskaplig artikel vědecký článek научная статья teaduslik artikkel article scientifique scientific article published on 2 September 2016 artikull shkencor 2016 թվականի սեպտեմբերի 2-ին հրատարակված գիտական հոդված 2016年學術文章 научни чланак บทความทางวิทยาศาสตร์ artigo científico 2016年学术文章 wetenschappelijk artikel სამეცნიერო სტატია article scientific 2016年学术文章 2016年學術文章 artículu científicu articolo scientifico מאמר מדעי 2016年学术文章
p:P577
wds:Q45297326-5EA30B06-7548-44C5-958C-C83F1DC4A94C
wdt:P577
2016-09-02T00:00:00Z
p:P407
wds:Q45297326-942EFF31-76F7-4653-9983-038CF606B2EE
wdt:P407
wd:Q1860
p:P2860
wds:Q45297326-1FDDF9C4-D7E7-4EF0-9CEA-02CEDF5B67E2 wds:Q45297326-202058CF-F3B6-4813-A42B-00FEF39303A2 wds:Q45297326-221ED367-D6D2-45C6-B884-CA87CD919A74 wds:Q45297326-38E151E8-56CF-4C7F-A7F5-8C406142C31A wds:Q45297326-4588E1C8-2EA7-496F-A33B-4B525C836242 wds:Q45297326-46CCD570-D2CE-4AAC-BFC5-0EC85627A024 wds:Q45297326-4C02D6D5-A941-472B-A5FA-49B1F2E1D7E1 wds:Q45297326-57897D2F-F724-4F92-AB68-FE8B71CD9EFF wds:Q45297326-69CFF471-2E25-4AF7-B7F5-E7EC3808C62B wds:Q45297326-6DF00015-C7C5-46A6-8632-CB1A539EECD6 wds:Q45297326-768AA708-F349-46BA-B61C-F88C53DCB5D8 wds:Q45297326-7D48178C-0986-478D-81C7-59757339AC90 wds:Q45297326-9BC7778B-C2A0-456A-A1EC-D5625245848B wds:Q45297326-9D8656FC-C153-48DC-A38D-34782C1BB940 wds:Q45297326-A387D55B-2982-40FB-BB68-2E5422005749 wds:Q45297326-A4168E19-74A2-4DAD-A299-B84BBEAE4C10 wds:Q45297326-AE621DF2-99CF-46FB-B6D7-7C7BD95C060D wds:Q45297326-D8291780-D7B1-4080-A075-ED0AAE5ECE40 wds:Q45297326-E50CD387-66F6-4C66-9C62-1323558C58E5 wds:Q45297326-F7AE6FF3-7BCB-4AA4-BD98-A93DF5D8F1B3 wds:Q45297326-FDB97B9A-B8AA-46C0-8890-2F03A94FBF62 wds:Q45297326-04F6FBFD-E0FC-4190-A7C6-E52362BB11DD wds:Q45297326-11E9546B-EEC3-4C57-A110-1F3BDD80C512 wds:Q45297326-14140402-43D3-4407-A0C0-784C90DDFCAA
wdt:P2860
wd:Q81637996 wd:Q34201679 wd:Q39768068 wd:Q34360204 wd:Q60632052 wd:Q48693496 wd:Q47913432 wd:Q39408906 wd:Q53641303 wd:Q38171268 wd:Q34430848 wd:Q41452053 wd:Q43049820 wd:Q36883469 wd:Q26750711 wd:Q48065984 wd:Q33836152 wd:Q36998180 wd:Q39090432 wd:Q40693199 wd:Q47249808 wd:Q34903683 wd:Q33447966 wd:Q51026334
p:P2093
wds:Q45297326-31A8E841-9CDA-4E02-A465-53A90CDB66A5 wds:Q45297326-3293D3A5-1B10-4D64-AF9A-ED5E59A6EC79 wds:Q45297326-30E36A89-A82B-447F-BE51-FFF5F60D34ED wds:Q45297326-6D9C72CB-905A-4BE3-85E3-758ACBCDBC4D wds:Q45297326-0C4070CD-FAA3-48C2-8806-A4135C4F5129 wds:Q45297326-0635BD6A-055A-4E5A-8184-2A0C95BB4EBE wds:Q45297326-E97D7762-6E71-4826-A6BA-248E170574FC wds:Q45297326-90AB2AB6-D75B-4CB2-BDB3-78B0A24E686F wds:Q45297326-7EDD6D1E-0AB8-47AF-83FF-3ED22EBDFC32 wds:Q45297326-A59E6B45-27BC-4A12-A7DE-B8E5535DF5F5 wds:Q45297326-9EDA3B92-DAE6-4DC8-9D2F-EC04E4D035DF
wdt:P2093
Viktoria Werkström Pascal Chanez J Mark FitzGerald Steven F Weinstein Mitchell Goldman Peter Barker Geoffrey Gilmartin Stephanie Sproule SIROCCO study investigators Alberto Papi Magnus Aurivillius
rdfs:label
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
skos:prefLabel
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
schema:name
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
p:P50
wds:Q45297326-7031EABA-C241-4351-9733-D89C94DF9716
wdt:P50
wd:Q65560413
p:P1476
wds:Q45297326-51271136-6841-4A3E-A7F8-B78396FB9D12
wdt:P1476
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
p:P304
wds:Q45297326-07414C5E-AB87-441F-9A07-D09D7762D296
wdt:P304
2115-2127
p:P31
wds:Q45297326-C3E61F5B-1A34-4A54-B26C-F067203498C2
wdt:P31
wd:Q13442814
p:P921
wds:Q45297326-B857E24C-B47E-48EC-9B62-3DBEA6DFF6C6 wds:Q45297326-E0AD58AB-3382-406F-BD8D-24852CBCAC9C wds:Q45297326-8FE7CACA-F304-4ABB-8089-FA652B6984FD wds:Q45297326-00348B48-C2C1-4A3C-A39E-CBE966C5B71B wds:Q45297326-F5E4D67C-8124-4743-999C-D65566507D14
wdt:P921
wd:Q6934595 wd:Q181600 wd:Q35869 wd:Q42824827 wd:Q269829
p:P698
wds:Q45297326-2F26276A-C4A5-4F70-B47C-CBEE4BDC3C25
wdtn:P698
n12:27609408
wdt:P698
27609408
p:P1433
wds:Q45297326-AAEB1E8D-A2EE-4DA3-8981-B4D3EDE451E1
wdt:P1433
wd:Q939416
p:P433
wds:Q45297326-FF254341-22B6-4955-9BB0-FDB52B4D54D2
p:P478
wds:Q45297326-578063FE-655A-4E45-AD42-F1664DB2883D
wdt:P433
10056
wdt:P478
388
p:P356
wds:Q45297326-1EB365A3-5DA5-4C2C-80FF-90229C8738B6
wdtn:P356
n11:S0140-6736(16)31324-1
wdt:P356
10.1016/S0140-6736(16)31324-1